Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 810, Issue 1, 2004, Pages 25-34

  Colombo, S ^a   Guignard, N ^a   Marzolini, C ^a   Telenti, A ^b   Biollaz, J ^a   Decosterd, L A ^a  

^a Lab BH 18 218 Ctr Hosp Univ V   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Atazanavir; Non nucleoside reverse transcriptase inhibitors; Protease inhibitors

Indexed keywords

BODY FLUIDS; CHROMATOGRAPHY; PATIENT TREATMENT; PH EFFECTS; ULTRAVIOLET RADIATION;

HUMAN PLASMA; INDINAVIR;

BIOMEDICAL ENGINEERING;

AMPRENAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT; ATAZANAVIR; ATORVASTATIN; CLOZAPINE; DIDANOSINE; EFAVIRENZ; FOLINATE CALCIUM; INDINAVIR; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR; METHANOL; NELFINAVIR; NEVIRAPINE; NITROGEN; PANCREATIN; PHOSPHATE; PHOSPHORIC ACID; PROTEINASE INHIBITOR; PYRIMETHAMINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; SODIUM DERIVATIVE; SODIUM HEPTANESULFONATE; SODIUM HYDROXIDE; STAVUDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WATER;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; CONTROLLED STUDY; DIODE; DRUG DETERMINATION; DRUG ISOLATION; DRUG MONITORING; ELUTION; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PH; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROOM TEMPERATURE; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION; VALIDATION PROCESS; VIRUS INHIBITION;

AMBYSTOMA TIGRINUM STEBBENSI VIRUS;

EID: 4444239810     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(04)00580-X     Document Type: Article

References (23)

1. F.J. Palella, and K.M. Delaney A. C. N. Engl. J. Med. 338 1998 853
2. F.W. Wit, R. van Leeuven, and G.J. Weverling J. Infect. Dis. 179 1999 790
3. P.J. Piliero Expert Opin. Invest. Drugs 11 2002 1295
4. R.J. Colonno, A. Thiry, K. Limoni, and N. Parkin Antimicrob. Agent Chemother. 47 2003 1324
5. I. Sanne, P. Piliero, K. Squires, and S. Schnittman J. Acquir. Immune Defic. Syndr. 1 32 2003 18 29
6. Investigator Brochure Atazanavir BMS-232632, version 5, November 2003, p. 24.
7. C. Marzolini, A. Telenti, T. Buclin, J. Biollaz, and L.A. Decosterd J. Chromatogr. B (Biomed. Sci. Appl.) 740 2000 43
8. C. Marzolini, A. Beguin, A. Telenti, A. Schreyer, T. Buclin, J. Biollaz, and L.A. Decosterd J. Chromatogr. B 774 2002 127
9. M. Jemal, S. Rao, M. Gatz, and D. Whigan J. Chromatogr. B 795 2003 273
10. A. Schuster, S. Burzawa, M. Jemal, E. Loizillon, P. Couerbe, and D. Whigan J. Chromatogr. B 788 2003 377
11. K.M.L. Crommentuyn, H. Rosing, M.J.X. Hillebrand, A.D.R. Huitema, and J.H. Beijnen J. Chromatogr. B 804 2004 359
12. V.P. Shah, K.K. Midha, S. Dighe, I.J. McGilveray, J.P. Skelly, A. Yacobi, T. Layloff, C.T. Viswanathan, C.E. Cook, and R.D. McDowall Eur. J. Drug Metabol. Pharm. 16 1991 249
13. FDA Home page. Guidance for industry: bioanalytical method validation. http://www.fda.gov/cder/guidance/4252fnl.htm, May 2001.
14. J.S. McDougal, L.S. Martin, S.P. Cort, M. Mozen, C.M. Heldebrant, and B.L. Evatt J. Clin. Invest. 76 1985 875
15. S.S. Good, D.J. Reynolds, and P. De Miranda J. Chromatogr. 431 1988 123
16. G.V. Quinnan Jr., M.A. Wells, A.E. Wittek, M.A. Phelan, R.E. Mayner, S. Feinstone, R.H. Purcell, and J.S. Epstein Transfusion 26 1986 481
17. C.H.W. Koks, H. Rosing, P.L. Meenhorst, A. Bult, and J.H. Beijnen J. Chromatogr. B 663 1995 345
18. V.P. Shah, K.K. Midha, J.W. Findlay, H.M. Hill, J.D. Hulse, I.J. McGilveray, G. McKay, K.J. Miller, R.N. Patnaik, M.L. Powell, A. Tonelli, C.T. Viswanathan, and A. Yacobi Pharm. Res. 17 2000 1551
19. G.W. Snedecor, W.G. Cochran, Statistical Methods, eighth ed., Iowa-State University Press, 1989, p. 252.
20. S. Preston; P. Piliero, E. O'Mara, et al., in: Proceedings of Ninth Conference on Retroviruses and Opportunistic Infections CROI, abstract #443, Seattle, Washington, 2002.
21. Reytaz [package insert], Bristol-Myers Squibb Company, Princeton, NJ, 2003.
22. D. Tackett, M. Child, S. Agarwala, M. Geiger, M. Geraldes, B. Laura, E O'Mara, in: Proceedings of Ninth Conference on Retroviruses and Opportunistic Infections CROI, abstract #543, Seattle, Washington, 2002.
23. S. Kaul, K. Bassi, B. Damle, et al., in: Proceedings of 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy ICAAC, abstract #1616, Chicago, Illinois, 2003.